Finished Dose Custom Services
Serving the pharmaceutical and biopharmaceutical markets with finished dosage services, we offer superior customer service and technical expertise that positions us among leading Chinese CMOs in China.
The value delivered by Hisun’s Finished Dosage Service centers on a technologically-advanced sites in China with emphasis on injectables and special delivery technology platforms, unparalleled experience and regulatory expertise, and the foresight and framework for sustainability, all which foster security of supply for customers.
Oral
- Immediate-release
- Sustained and controlled release
Injection
- Normal injection
- Depot injection
- Targeted drug product
- Nanoparticles
- Nanomicelles
- Liposomes
Transdermal
- Transdermal patch
- Implant
Inhalation
- Atomizing products
- Aerosol products
- Dry powder inhalation
- Nasal spray products
Solid Dosage Capability
- Blending, granulation, compression and encapsulation
- Coating
- Drying Printing, embossing and banding
- Bottle packaging
- Blister packaging
- Pouch/packet packaging
- Technology services
Solid Dosage Capacity
Pilot Plant
- Tablets: 3M/year
Production Plant
- Tablets: 7B/year
- Capsules: 2B/year
Injectable Capability
Filling
- Gravimetrically controlled fill checks
- Low particle aseptic techniques
- Protection of photosensitive products
- Inert headspace atmosphere in the container
- Automatic stoppering and traying
Lyophillization
- Cytotoxic compounds with isolators
- C_RABS (Closed-Restricted Access Barrier System) Technology
- Total 160m2 of lyophilize capacity, with variety of chamber size between 5-20m2
- Automatic Loading and Unloading System (ALUS)
Injectable Capacity
- 0.25-15 Million vials/year
- 1-100 mL volume/vial